Systematic review / meta-analysis / 2015
Elevated homocysteine levels were linked to increased cardiovascular and all-cause mortality.
A meta-analysis of 12 prospective observational studies with 23,623 participants evaluated baseline homocysteine levels and mortality. Comparing the highest to lowest categories, participants with elevated homocysteine had higher risks of coronary heart disease mortality (RR 1.66; 95% CI: 1.12-2.47), cardiovascular mortality (RR 1.68; 95% CI: 1.04-2.70), and all-cause mortality (RR 1.93; 95% CI: 1.54-2.43). Each 5 μmol/L increase was also associated with elevated mortality across all three outcomes.
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis of prospective observational studies
- Who was studied
- 12 prospective observational studies, 23,623 participants
- What was measured
- Coronary heart disease, cardiovascular, and all-cause mortality
THE PAPER
Elevated homocysteine levels and risk of cardiovascular and all-cause mortality: a meta-analysis of prospective studies.
Peng HY, Man CF, Xu J, Fan Y. J Zhejiang Univ Sci B, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.